About EITR BIOLOGICS, INC.
Eitr Biologics is a biotechnology company focused on developing next-generation immunotherapeutics using its ODIN platform, targeting oncology and infectious diseases. The company is based in San Diego and emphasizes global accessibility to life-saving treatments.
Development of next-generation immunotherapeuticsCreation of the world’s smallest single domain bispecific for oncologyDesign of ODIN molecules to penetrate gram-negative bacteria and viral reservoirsPlatform technologies for antibody discovery and research
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED | Department of Defense | $500K | |
| THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE | Department of Health and Human Services | $31.2M | |
| NOVEL NANOTHERAPEUTICS | Department of Defense | $1.9M | |
| NOVEL NANOTHERAPEUTIC APPROACHES PENETRATING THE OUTER LAYERS OF THE BACTERIUM AND TARGETING OUTER MEMBRANE PR | Department of Defense | $750K | |
| NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | Department of Defense | $270K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EITR BIOLOGICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.